Beta cell mass regulation in the rat pancreas through glucocorticoids and thyroid hormones
To compare the effects of glucocorticoids and thyroid hormones on the regulation of the beta cell mass in the pancreas, the rats were treated and analyzed for cell cycle changes in islet and duct cells as a source for beta cell neogenesis. Different rat pancreases were morphometrically analyzed afte...
Gespeichert in:
Veröffentlicht in: | Pancreas 2010-11, Vol.39 (8), p.1167-1172 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1172 |
---|---|
container_issue | 8 |
container_start_page | 1167 |
container_title | Pancreas |
container_volume | 39 |
creator | Jörns, Anne Sennholz, Christoph Naujok, Ortwin Lenzen, Sigurd |
description | To compare the effects of glucocorticoids and thyroid hormones on the regulation of the beta cell mass in the pancreas, the rats were treated and analyzed for cell cycle changes in islet and duct cells as a source for beta cell neogenesis.
Different rat pancreases were morphometrically analyzed after immunohistochemical staining for markers of proliferation and apoptosis.
Hydrocortisone increased the beta cell mass of rat pancreases through an increase of proliferation. This effect was counteracted by an increase of apoptosis. In contrast, thyroxine decreased the beta cell mass through an increase of apoptosis. This effect was counteracted by an increased rate of proliferation. Combined treatment with both hormones nullified the antagonistic effects on proliferation, apoptosis, and beta cell mass, thereby contributing to the maintenance of a stable total beta cell volume of the pancreas.
Hydrocortisone and thyroxine induced analogous changes in pancreatic duct cells, which represent a crucial pool for new beta cells through neogenesis. This may explain the positive effects of glucocorticoids in the immunosuppressive therapy regimen after whole pancreas transplantation upon long-term insulin independence, which is not achievable with isolated islets because of the loss of duct cells during the islet process before transplantation. |
doi_str_mv | 10.1097/MPA.0b013e3181dfce4f |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_758838806</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>758838806</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-4746a766779f4a307e9ca094a02f2fa30c7452258bbf265542f352ad9eb9df643</originalsourceid><addsrcrecordid>eNpdkMtOwzAQRS0EoqXwBwh5xyrF78eyIF5SESxgwyZyHLsNSuJiO4v-PalaWLAazZ17ZzQHgEuM5hhpefPytpijCmHqKFa49tYxfwSmmFNRMEXUMZgipXhBsZQTcJbSF0JYUq5PwYQgoSjBego-b1020Lq2hZ1JCUa3GlqTm9DDpod57WA0GW5Mb6MzaRRiGFZruGoHG2yIubGhqRM0fT3OtnFs4DrELvQunYMTb9rkLg51Bj4e7t_vnorl6-Pz3WJZWCpJLphkwkghpNSeGYqk09YgzQwinvhRsJJxQriqKk8E54x4yomptat07QWjM3C937uJ4XtwKZddk3Yfmd6FIZWSK0WVQmJ0sr3TxpBSdL7cxKYzcVtiVO6gliPU8j_UMXZ1ODBUnav_Qr8U6Q-biXVx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>758838806</pqid></control><display><type>article</type><title>Beta cell mass regulation in the rat pancreas through glucocorticoids and thyroid hormones</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Jörns, Anne ; Sennholz, Christoph ; Naujok, Ortwin ; Lenzen, Sigurd</creator><creatorcontrib>Jörns, Anne ; Sennholz, Christoph ; Naujok, Ortwin ; Lenzen, Sigurd</creatorcontrib><description>To compare the effects of glucocorticoids and thyroid hormones on the regulation of the beta cell mass in the pancreas, the rats were treated and analyzed for cell cycle changes in islet and duct cells as a source for beta cell neogenesis.
Different rat pancreases were morphometrically analyzed after immunohistochemical staining for markers of proliferation and apoptosis.
Hydrocortisone increased the beta cell mass of rat pancreases through an increase of proliferation. This effect was counteracted by an increase of apoptosis. In contrast, thyroxine decreased the beta cell mass through an increase of apoptosis. This effect was counteracted by an increased rate of proliferation. Combined treatment with both hormones nullified the antagonistic effects on proliferation, apoptosis, and beta cell mass, thereby contributing to the maintenance of a stable total beta cell volume of the pancreas.
Hydrocortisone and thyroxine induced analogous changes in pancreatic duct cells, which represent a crucial pool for new beta cells through neogenesis. This may explain the positive effects of glucocorticoids in the immunosuppressive therapy regimen after whole pancreas transplantation upon long-term insulin independence, which is not achievable with isolated islets because of the loss of duct cells during the islet process before transplantation.</description><identifier>ISSN: 0885-3177</identifier><identifier>EISSN: 1536-4828</identifier><identifier>DOI: 10.1097/MPA.0b013e3181dfce4f</identifier><identifier>PMID: 20683219</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Apoptosis - drug effects ; Bromodeoxyuridine - metabolism ; Cell Count ; Cell Proliferation - drug effects ; Glucocorticoids - pharmacology ; Homeodomain Proteins - metabolism ; Hydrocortisone - pharmacology ; Immunohistochemistry ; In Situ Nick-End Labeling ; Insulin-Secreting Cells - cytology ; Insulin-Secreting Cells - drug effects ; Insulin-Secreting Cells - metabolism ; Pancreatic Ducts - cytology ; Pancreatic Ducts - drug effects ; Pancreatic Ducts - metabolism ; Rats ; Rats, Inbred Lew ; Thyroid Hormones - pharmacology ; Thyroxine - pharmacology ; Trans-Activators - metabolism</subject><ispartof>Pancreas, 2010-11, Vol.39 (8), p.1167-1172</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-4746a766779f4a307e9ca094a02f2fa30c7452258bbf265542f352ad9eb9df643</citedby><cites>FETCH-LOGICAL-c372t-4746a766779f4a307e9ca094a02f2fa30c7452258bbf265542f352ad9eb9df643</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20683219$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jörns, Anne</creatorcontrib><creatorcontrib>Sennholz, Christoph</creatorcontrib><creatorcontrib>Naujok, Ortwin</creatorcontrib><creatorcontrib>Lenzen, Sigurd</creatorcontrib><title>Beta cell mass regulation in the rat pancreas through glucocorticoids and thyroid hormones</title><title>Pancreas</title><addtitle>Pancreas</addtitle><description>To compare the effects of glucocorticoids and thyroid hormones on the regulation of the beta cell mass in the pancreas, the rats were treated and analyzed for cell cycle changes in islet and duct cells as a source for beta cell neogenesis.
Different rat pancreases were morphometrically analyzed after immunohistochemical staining for markers of proliferation and apoptosis.
Hydrocortisone increased the beta cell mass of rat pancreases through an increase of proliferation. This effect was counteracted by an increase of apoptosis. In contrast, thyroxine decreased the beta cell mass through an increase of apoptosis. This effect was counteracted by an increased rate of proliferation. Combined treatment with both hormones nullified the antagonistic effects on proliferation, apoptosis, and beta cell mass, thereby contributing to the maintenance of a stable total beta cell volume of the pancreas.
Hydrocortisone and thyroxine induced analogous changes in pancreatic duct cells, which represent a crucial pool for new beta cells through neogenesis. This may explain the positive effects of glucocorticoids in the immunosuppressive therapy regimen after whole pancreas transplantation upon long-term insulin independence, which is not achievable with isolated islets because of the loss of duct cells during the islet process before transplantation.</description><subject>Animals</subject><subject>Apoptosis - drug effects</subject><subject>Bromodeoxyuridine - metabolism</subject><subject>Cell Count</subject><subject>Cell Proliferation - drug effects</subject><subject>Glucocorticoids - pharmacology</subject><subject>Homeodomain Proteins - metabolism</subject><subject>Hydrocortisone - pharmacology</subject><subject>Immunohistochemistry</subject><subject>In Situ Nick-End Labeling</subject><subject>Insulin-Secreting Cells - cytology</subject><subject>Insulin-Secreting Cells - drug effects</subject><subject>Insulin-Secreting Cells - metabolism</subject><subject>Pancreatic Ducts - cytology</subject><subject>Pancreatic Ducts - drug effects</subject><subject>Pancreatic Ducts - metabolism</subject><subject>Rats</subject><subject>Rats, Inbred Lew</subject><subject>Thyroid Hormones - pharmacology</subject><subject>Thyroxine - pharmacology</subject><subject>Trans-Activators - metabolism</subject><issn>0885-3177</issn><issn>1536-4828</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkMtOwzAQRS0EoqXwBwh5xyrF78eyIF5SESxgwyZyHLsNSuJiO4v-PalaWLAazZ17ZzQHgEuM5hhpefPytpijCmHqKFa49tYxfwSmmFNRMEXUMZgipXhBsZQTcJbSF0JYUq5PwYQgoSjBego-b1020Lq2hZ1JCUa3GlqTm9DDpod57WA0GW5Mb6MzaRRiGFZruGoHG2yIubGhqRM0fT3OtnFs4DrELvQunYMTb9rkLg51Bj4e7t_vnorl6-Pz3WJZWCpJLphkwkghpNSeGYqk09YgzQwinvhRsJJxQriqKk8E54x4yomptat07QWjM3C937uJ4XtwKZddk3Yfmd6FIZWSK0WVQmJ0sr3TxpBSdL7cxKYzcVtiVO6gliPU8j_UMXZ1ODBUnav_Qr8U6Q-biXVx</recordid><startdate>201011</startdate><enddate>201011</enddate><creator>Jörns, Anne</creator><creator>Sennholz, Christoph</creator><creator>Naujok, Ortwin</creator><creator>Lenzen, Sigurd</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201011</creationdate><title>Beta cell mass regulation in the rat pancreas through glucocorticoids and thyroid hormones</title><author>Jörns, Anne ; Sennholz, Christoph ; Naujok, Ortwin ; Lenzen, Sigurd</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-4746a766779f4a307e9ca094a02f2fa30c7452258bbf265542f352ad9eb9df643</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Animals</topic><topic>Apoptosis - drug effects</topic><topic>Bromodeoxyuridine - metabolism</topic><topic>Cell Count</topic><topic>Cell Proliferation - drug effects</topic><topic>Glucocorticoids - pharmacology</topic><topic>Homeodomain Proteins - metabolism</topic><topic>Hydrocortisone - pharmacology</topic><topic>Immunohistochemistry</topic><topic>In Situ Nick-End Labeling</topic><topic>Insulin-Secreting Cells - cytology</topic><topic>Insulin-Secreting Cells - drug effects</topic><topic>Insulin-Secreting Cells - metabolism</topic><topic>Pancreatic Ducts - cytology</topic><topic>Pancreatic Ducts - drug effects</topic><topic>Pancreatic Ducts - metabolism</topic><topic>Rats</topic><topic>Rats, Inbred Lew</topic><topic>Thyroid Hormones - pharmacology</topic><topic>Thyroxine - pharmacology</topic><topic>Trans-Activators - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jörns, Anne</creatorcontrib><creatorcontrib>Sennholz, Christoph</creatorcontrib><creatorcontrib>Naujok, Ortwin</creatorcontrib><creatorcontrib>Lenzen, Sigurd</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pancreas</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jörns, Anne</au><au>Sennholz, Christoph</au><au>Naujok, Ortwin</au><au>Lenzen, Sigurd</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Beta cell mass regulation in the rat pancreas through glucocorticoids and thyroid hormones</atitle><jtitle>Pancreas</jtitle><addtitle>Pancreas</addtitle><date>2010-11</date><risdate>2010</risdate><volume>39</volume><issue>8</issue><spage>1167</spage><epage>1172</epage><pages>1167-1172</pages><issn>0885-3177</issn><eissn>1536-4828</eissn><abstract>To compare the effects of glucocorticoids and thyroid hormones on the regulation of the beta cell mass in the pancreas, the rats were treated and analyzed for cell cycle changes in islet and duct cells as a source for beta cell neogenesis.
Different rat pancreases were morphometrically analyzed after immunohistochemical staining for markers of proliferation and apoptosis.
Hydrocortisone increased the beta cell mass of rat pancreases through an increase of proliferation. This effect was counteracted by an increase of apoptosis. In contrast, thyroxine decreased the beta cell mass through an increase of apoptosis. This effect was counteracted by an increased rate of proliferation. Combined treatment with both hormones nullified the antagonistic effects on proliferation, apoptosis, and beta cell mass, thereby contributing to the maintenance of a stable total beta cell volume of the pancreas.
Hydrocortisone and thyroxine induced analogous changes in pancreatic duct cells, which represent a crucial pool for new beta cells through neogenesis. This may explain the positive effects of glucocorticoids in the immunosuppressive therapy regimen after whole pancreas transplantation upon long-term insulin independence, which is not achievable with isolated islets because of the loss of duct cells during the islet process before transplantation.</abstract><cop>United States</cop><pmid>20683219</pmid><doi>10.1097/MPA.0b013e3181dfce4f</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0885-3177 |
ispartof | Pancreas, 2010-11, Vol.39 (8), p.1167-1172 |
issn | 0885-3177 1536-4828 |
language | eng |
recordid | cdi_proquest_miscellaneous_758838806 |
source | MEDLINE; Journals@Ovid Complete |
subjects | Animals Apoptosis - drug effects Bromodeoxyuridine - metabolism Cell Count Cell Proliferation - drug effects Glucocorticoids - pharmacology Homeodomain Proteins - metabolism Hydrocortisone - pharmacology Immunohistochemistry In Situ Nick-End Labeling Insulin-Secreting Cells - cytology Insulin-Secreting Cells - drug effects Insulin-Secreting Cells - metabolism Pancreatic Ducts - cytology Pancreatic Ducts - drug effects Pancreatic Ducts - metabolism Rats Rats, Inbred Lew Thyroid Hormones - pharmacology Thyroxine - pharmacology Trans-Activators - metabolism |
title | Beta cell mass regulation in the rat pancreas through glucocorticoids and thyroid hormones |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T05%3A48%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Beta%20cell%20mass%20regulation%20in%20the%20rat%20pancreas%20through%20glucocorticoids%20and%20thyroid%20hormones&rft.jtitle=Pancreas&rft.au=J%C3%B6rns,%20Anne&rft.date=2010-11&rft.volume=39&rft.issue=8&rft.spage=1167&rft.epage=1172&rft.pages=1167-1172&rft.issn=0885-3177&rft.eissn=1536-4828&rft_id=info:doi/10.1097/MPA.0b013e3181dfce4f&rft_dat=%3Cproquest_cross%3E758838806%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=758838806&rft_id=info:pmid/20683219&rfr_iscdi=true |